ECMO criteria for influenza A (H1N1)-associated ARDS: role of transpulmonary pressure

Salvatore Grasso, Pierpaolo Terragni, Alberto Birocco, Rosario Urbino, Lorenzo Del Sorbo, Claudia Filippini, Luciana Mascia, Antonio Pesenti, Alberto Zangrillo, Luciano Gattinoni, V Marco Ranieri, Salvatore Grasso, Pierpaolo Terragni, Alberto Birocco, Rosario Urbino, Lorenzo Del Sorbo, Claudia Filippini, Luciana Mascia, Antonio Pesenti, Alberto Zangrillo, Luciano Gattinoni, V Marco Ranieri

Abstract

Purpose: To assess whether partitioning the elastance of the respiratory system (E (RS)) between lung (E (L)) and chest wall (E (CW)) elastance in order to target values of end-inspiratory transpulmonary pressure (PPLAT(L)) close to its upper physiological limit (25 cmH(2)O) may optimize oxygenation allowing conventional treatment in patients with influenza A (H1N1)-associated ARDS referred for extracorporeal membrane oxygenation (ECMO).

Methods: Prospective data collection of patients with influenza A (H1N1)-associated ARDS referred for ECMO (October 2009-January 2010). Esophageal pressure was used to (a) partition respiratory mechanics between lung and chest wall, (b) titrate positive end-expiratory pressure (PEEP) to target the upper physiological limit of PPLAT(L) (25 cmH(2)O).

Results: Fourteen patients were referred for ECMO. In seven patients PPLAT(L) was 27.2 ± 1.2 cmH(2)O; all these patients underwent ECMO. In the other seven patients, PPLAT(L) was 16.6 ± 2.9 cmH(2)O. Raising PEEP (from 17.9 ± 1.2 to 22.3 ± 1.4 cmH(2)O, P = 0.0001) to approach the upper physiological limit of transpulmonary pressure (PPLAT(L) = 25.3 ± 1.7 cm H(2)O) improved oxygenation index (from 37.4 ± 3.7 to 16.5 ± 1.4, P = 0.0001) allowing patients to be treated with conventional ventilation.

Conclusions: Abnormalities of chest wall mechanics may be present in some patients with influenza A (H1N1)-associated ARDS. These abnormalities may not be inferred from measurements of end-inspiratory plateau pressure of the respiratory system (PPLAT(RS)). In these patients, titrating PEEP to PPLAT(RS) may overestimate the incidence of hypoxemia refractory to conventional ventilation leading to inappropriate use of ECMO.

References

    1. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1082-91
    1. Anesthesiology. 2009 Oct;111(4):826-35
    1. J Appl Physiol. 1975 May;38(5):896-9
    1. Chest. 2010 Apr;137(4):745-7
    1. JAMA. 2011 Oct 19;306(15):1659-68
    1. Intensive Care Med. 2011 Sep;37(9):1447-57
    1. JAMA. 2009 Nov 4;302(17):1888-95
    1. Obes Rev. 2011 Aug;12(8):653-9
    1. N Engl J Med. 2000 May 4;342(18):1301-8
    1. J Clin Invest. 1957 Dec;36(12):1680-7
    1. Am Rev Respir Dis. 1984 Jan;129(1):39-44
    1. Crit Care Med. 2003 Jan;31(1):89-92
    1. JAMA. 2010 Mar 3;303(9):865-73
    1. Crit Care. 2004 Oct;8(5):350-5
    1. Am J Respir Crit Care Med. 2001 Sep 1;164(5):795-801
    1. Am J Respir Crit Care Med. 2007 Jan 15;175(2):160-6
    1. N Engl J Med. 2004 Jul 22;351(4):327-36
    1. Am J Respir Crit Care Med. 1994 Jan;149(1):19-27
    1. Crit Care Med. 2010 Jun;38(6):1484-5
    1. Crit Care Med. 2010 Nov;38(11):2103-7
    1. Can J Anaesth. 2010 Mar;57(3):240-7
    1. Crit Care Med. 2004 Apr;32(4):1018-27
    1. Anesthesiology. 2002 Apr;96(4):795-802
    1. Chest. 2010 Oct;138(4):778-81; discussion 782-4
    1. Crit Care. 2011;15(3):R133
    1. JAMA. 2008 Feb 13;299(6):646-55
    1. Am J Respir Crit Care Med. 1998 Jul;158(1):3-11
    1. Minerva Anestesiol. 2010 Dec;76(12):1043-51
    1. Am Rev Respir Dis. 1988 Sep;138(3):720-3
    1. J Appl Physiol (1985). 1987 Dec;63(6):2467-75
    1. Crit Care Med. 2007 Jan;35(1):214-21
    1. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1172-8
    1. Chest. 2010 Oct;138(4):776-8
    1. Anesthesiology. 2000 Nov;93(5):1320-8
    1. Hong Kong Med J. 2010 Dec;16(6):447-54
    1. Am J Respir Crit Care Med. 2009 Sep 1;180(5):415-23
    1. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):846-54
    1. Am J Respir Crit Care Med. 2007 Oct 15;176(8):761-7
    1. J Appl Physiol. 1964 Mar;19:207-11
    1. J Appl Physiol (1985). 2010 Jan;108(1):206-11
    1. Crit Care Med. 2010 Jun;38(6):1398-404
    1. J Appl Physiol (1985). 2010 Mar;108(3):481-2
    1. JAMA. 2008 Feb 13;299(6):637-45
    1. Am J Respir Crit Care Med. 2005 Nov 15;172(10):1241-5
    1. Lancet. 2009 Oct 17;374(9698):1351-63
    1. Curr Opin Crit Care. 2008 Feb;14(1):94-102
    1. Am Rev Respir Dis. 1993 Jan;147(1):5-13
    1. Am J Respir Crit Care Med. 2008 Dec 1;178(11):1156-63
    1. J Appl Physiol Respir Environ Exerc Physiol. 1979 Oct;47(4):683-91
    1. N Engl J Med. 2008 Nov 13;359(20):2095-104
    1. Intensive Care Med. 2010 Nov;36(11):1899-905
    1. Crit Care Med. 2006 May;34(5):1556-8
    1. Am J Respir Crit Care Med. 2006 Aug 1;174(3):268-78

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe